SILVESTRI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 462
EU - Europa 388
AS - Asia 95
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 972
Nazione #
US - Stati Uniti d'America 460
IT - Italia 241
SE - Svezia 65
SG - Singapore 41
BG - Bulgaria 24
CN - Cina 22
DE - Germania 22
CI - Costa d'Avorio 16
GB - Regno Unito 15
VN - Vietnam 10
IN - India 9
SN - Senegal 8
HK - Hong Kong 6
CH - Svizzera 5
RU - Federazione Russa 5
FI - Finlandia 3
PK - Pakistan 3
CA - Canada 2
FR - Francia 2
TR - Turchia 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EU - Europa 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
UA - Ucraina 1
Totale 972
Città #
Fairfield 69
Milan 59
Chandler 50
Cambridge 37
Serra 36
Ashburn 35
Ann Arbor 32
Seattle 29
Houston 27
Florence 26
Sofia 24
Woodbridge 22
New York 18
Pisa 18
Abidjan 16
Wilmington 13
Lucca 12
Princeton 12
Lawrence 10
Singapore 10
Genoa 9
Livorno 9
London 9
Dakar 8
Nettuno 8
Ogden 8
Frankfurt am Main 7
Medford 7
Hong Kong 6
Bern 5
Beijing 4
Boardman 4
Bremen 4
Dong Ket 4
Hyderabad 4
Kent 4
Viareggio 4
Guangzhou 3
Islamabad 3
Pune 3
Acton 2
Des Moines 2
Lappeenranta 2
Nürnberg 2
Ottawa 2
Redwood City 2
Rome 2
San Diego 2
San Giuliano Terme 2
Washington 2
Augusta 1
Brno 1
Buffalo 1
Camerino 1
Cascina 1
Castel Madama 1
Cedar Knolls 1
Chengdu 1
Colle di Val d'Elsa 1
Cormeilles-en-Parisis 1
Dallas 1
Dearborn 1
Encino 1
Esslingen am Neckar 1
Faggiano 1
Fremont 1
Groningen 1
Hangzhou 1
Jacksonville 1
Kilburn 1
Kocaeli 1
Lagos 1
Lancaster 1
Marseille 1
Massa 1
Nanchang 1
Nanjing 1
New Bedfont 1
Phoenix 1
San Francisco 1
Shanghai 1
Sydney 1
Tacoma 1
Vienna 1
Vientiane 1
Warsaw 1
Totale 724
Nome #
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 173
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 141
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 96
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system 79
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 69
Evaluation of the Anti-Spike (RDB) IgG Titer among Workers Employed at the University of Pisa Vaccinated with Different Types of SARS-CoV-2 Vaccines 59
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 58
DNA polymerases in the risk and prognosis of colorectal and pancreatic cancers 57
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 56
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report) 50
Role of Prosaposin and Extracellular Sulfatase Sulf-1 Detection in Pleural Effusions as Diagnostic Biomarkers of Malignant Mesothelioma 46
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma 42
Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide 40
Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach 34
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 18
Calcium signalling pathways in prostate cancer initiation and progression 9
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 5
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells 4
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 3
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy 2
Totale 1.041
Categoria #
all - tutte 3.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020120 5 2 37 5 10 9 10 10 12 13 4 3
2020/2021115 3 3 3 1 3 2 45 2 18 12 7 16
2021/2022156 10 15 18 6 18 17 12 3 13 4 13 27
2022/2023237 21 28 14 15 14 26 4 16 51 6 35 7
2023/2024310 49 24 51 23 35 34 14 14 3 6 32 25
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 1.041